S.494, the National Plan for Epilepsy Act, is an early-stage coordination bill with zero authorized spending. It creates an advisory council and mandates federal research coordination for epilepsy but appropriates no funds. Market impact is negligible — no direct revenue driver for any public company.
TICKER INTELLIGENCE
$UCBJY
Company & Legislative Profile
$UCBJY is a publicly traded company in the Healthcare sector. This company operates across Healthcare and is subject to various Congressional legislative and regulatory actions. HillSignal is tracking 1 active Congressional signal mentioning $UCBJY, including 1 bill. The legislative sentiment is currently mixed, with both supportive and challenging policy signals in play.
$UCBJY is currently facing 1 active congressional signal tracked by HillSignal. With 0 bullish, 1 neutral, and 0 bearish signal, covering 1 sector. Key sectors affected include Healthcare. Recent major catalysts include National Plan for Epilepsy Act. Below is the complete tracker of government activity affecting $UCBJY’s market performance.
1
Total Signals
2.0/10
Avg Impact
0
Bullish Signals
0
Bearish Signals
Related Sectors
Recent Congressional Signals for $UCBJY
Understanding These Signals
Get Full Access to $UCBJY Signals
Daily AI-analyzed alerts for Congressional activity affecting your portfolio.
Get Started →